首页> 外国专利> A MOUSE MODEL OF NONALCOHOLIC STEATOHEPATITIS AND USES THEREOF

A MOUSE MODEL OF NONALCOHOLIC STEATOHEPATITIS AND USES THEREOF

机译:壬酸脂肪肝的小鼠模型及其应用

摘要

An isogenic murine animal model for liver disease resulting from a Western (high fat, high sugar) diet is provided. This phenotypically and genotypically stable model sequentially develops steatosis (4-8 weeks), steatohepatitis (12-16 weeks), progressive fibrosis (16 week onwards) and spontaneous HCC (32-52 weeks), but only when fed a diet high in fat and sugar. The mice also develop obesity, insulin resistance and dyslipidemia, and the mouse hepatic transcriptome is concordant with the human NASH transcriptome at early and late time points, including activation of lipogenic, inflammatory and apoptotic signaling. The mouse HCC gene signature resembles S1 and S2 human HCC subclasses. This simple model of NASH and HCC that mirrors the development of human disease in terms of its triggers, serology, phenotype, histology, transcriptome and outcomes has utility in new target discovery, biomarker discovery, diagnostic test development, and screening and development of drugs for the corresponding liver conditions.
机译:提供了一种由西方饮食(高脂肪,高糖)引起的肝脏疾病的同基因鼠动物模型。这种表型和基因型稳定的模型依次发展为脂肪变性(4-8周),脂肪性肝炎(12-16周),进行性纤维化(16周起)和自发性肝癌(32-52周),但仅在高脂饮食下才能发展和糖。小鼠还出现肥胖,胰岛素抵抗和血脂异常,并且小鼠肝转录组在早期和晚期时间点都与人NASH转录组一致,包括激活脂原性,炎性和凋亡信号转导。小鼠HCC基因签名类似于S1和S2人HCC亚类。 NASH和HCC的这种简单模型从触发器,血清学,表型,组织学,转录组和结果等方面反映了人类疾病的发展,可用于新的靶标发现,生物标志物发现,诊断测试开发以及用于药物的筛选和开发相应的肝病。

著录项

  • 公开/公告号EP3361863A4

    专利类型

  • 公开/公告日2019-10-16

    原文格式PDF

  • 申请/专利权人 VIRGINIA COMMONWEALTH UNIVERSITY;

    申请/专利号EP20160856056

  • 发明设计人 SANYAL ARUN;MIRSHAHI FARIDODDIN;

    申请日2016-10-12

  • 分类号A01K67;A01K67/027;

  • 国家 EP

  • 入库时间 2022-08-21 12:30:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号